Role of Comorbidities in Chronic Heart Failure Study

Inclusion Criteria: 1. Age \>= 18 2. NYHA (New York Heart Association) class II-IV symptoms 3. Left ventricular ejection fraction \< 50% at Visit 1. 4. Treatment according to current Heart Failure Guidelines of the European Society of Cardiology 5. Willingness and ability to provide signed informed consent form (ICF) prior to participation in any study-related procedures 6. Previous diagnosis of heart failure with reduced ejection fraction defined as symptomatic left ventricular ejection \< 40% requiring optimization of heart failure therapy Exclusion Criteria: 1. Unplanned hospitalization within 1 month prior to the Baseline Visit. 2. Discontinuation or initiation of a pharmacologic or device treatment for HFrEF within 1 month prior to the baseline visit. 3. Coronary or peripheral revascularization procedures, valvular procedures, OR any major surgical procedure within 3 months prior to the Screening Visit. 4. Acute coronary syndrome (ACS), stroke or transient ischemic attack (TIA) within 3 months prior to the Screening Visit. 5. Any acute illness 6. Disease reducing life expectancy to \< 1 year, except HFrEF 7. Recipient of any organ transplant 8. Primary significant valve disease (at least moderate to severe valve disease)